Bayer shares jumped in morning trade as the German life sciences company said it scored a legal victory in its suit over claims that exposure to its popular Roundup weed killer led to cancer.
The stock was up 11.67% at 11:44 a.m. London time.
The company on Thursday announced that the 3rd U.S. Circuit Court of Appeals in Philadelphia found in its favor against plaintiff David Schaffner’s claim alleging that the Monsanto corporation — which Bayer acquired in 2018 — violated state law by failing to add a cancer warning to the Roundup label.
This breaking news story is being updated.
Read the full article here
